- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03647605
Pilot Study: VR Mind and VR Mind+ Intervention
Pilot Study: Feasibility, Usability and Safety Assessment of VR Mind and VR Mind+ Intervention
The aim of the pilot study is feasibility, usability and safety assessment of VR Mind intervention. In particular the subject of assessment will be:
- the length of the laboratory session utilizing virtual reality exposure (feasibility),
- the ergonomics and ease of use for both patients and system operators (usability),
- the frequency of side effect occurrence as a result of virtual reality exposure (ie. Vertigo) (safety).
The results pilot study will be used in the designing a clinical trial aimed for testing efficacy and safety of VR Mind intervention.
Aperçu de l'étude
Description détaillée
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Mazowieckie
-
Warszawa, Mazowieckie, Pologne, 02-957
- Instytut Psychiatrii i Neurologii
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age: 18-50 y.o.
- Confirmed DSM-IV-TR criteria for Social Anxiety Disorder (SAD).
- Signing informed consent
Exclusion Criteria:
- Occurrence of SAD symptoms inconsistent with DSM-IV-TR criteria and with psychiatric interview (SCID-I; Structured Clinical Interview)
Occurrence and/or recognition:
- psychosis,
- bipolar disorder,
- mental retardation
Exclusion based on interview:
- pregnancy,
- drug addiction,
- alcohol addiction,
- participating in the experimental session while intoxicated
- (current) neurological treatment of chronic disease of central nervous system,
- epilepsy,
- paroxysmal vertigo,
- presence of suicidal thoughts , tendencies or attempts,
- participant is taking drugs from benzodiazepine group, other sedatives, narcotic drugs
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: VR Mind
Two VR Mind sessions using experimental virtual reality scenarios.
During these two sessions, participants will be exposed to virtual reality environment, for 2 x 10 min each session.
|
Two VR Mind sessions using virtual reality scenarios concerning social situations in which social phobics are prone to experience anxiety.
The pilot study will consist of two scenarios: "Public Speaking in Lecture Hall" and "Telephoning in Public".
Two sessions are planned, each containing two expositions to virtual reality environment, each lasting 10 minutes.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Feasibility_1: Number of participants, who have completed 4 laboratory sessions within 2 weeks.
Délai: At the end of 4th laboratory session within 2 weeks
|
Number of participants, who have completed 4 laboratory sessions within 2 weeks.
|
At the end of 4th laboratory session within 2 weeks
|
Feasibility_2: Number of virtual reality exposure sessions completed in predefined time.
Délai: At the end of 2nd and 3th laboratory session within 2 weeks
|
Number of virtual reality exposure sessions completed in predefined time.
|
At the end of 2nd and 3th laboratory session within 2 weeks
|
Usability_ 3: immersion, perceived reality and engagement
Délai: At the end of 2 and 3 laboratory session within 2 weeks
|
3 items with 7-point scale, where 1 is "Totally agree" and 7 "Totally disagree":
|
At the end of 2 and 3 laboratory session within 2 weeks
|
Safety_1: occurrence and severity of simulator sickness
Délai: During 2nd and 3th laboratory session within 2 weeks
|
Simulator sickness is expected adverse effect of the VR. Hence, the Simulator Sickness Questionnaire (SSQ; Kennedy, Lane, Berbaum, Lilienthal, 1993) will be administered as a primary outcome measure to evaluate safety of the VR intervention. Total SSQ score equal to or higher than 10 will be used as a preliminary cut-off for simulator sickness (Balk et al., 2013). Individual scores will be corrected for baseline (pre-VR) symptom severity. Only items with a pre-VR - post-VR increase will contribute to a final SSQ score. All post-intervention SSQ scores >10 will be analyzed further for its association with study drop-outs and other intervention required. The adverse effect will be classified as:
|
During 2nd and 3th laboratory session within 2 weeks
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Clinical Global Impression
Délai: During 1st and 4th session within 2 weeks
|
Clinical Global Impression (Guy, 1976) - is a single item, 7 point scale used by clinicians to asses the severity of illness, where 1 is labeled as "Normal, not at all ill" and 7 is labeled as "Among the most extremely ill patients".
|
During 1st and 4th session within 2 weeks
|
Patient Global Impression
Délai: During 1st and 4th session within 2 weeks
|
Patient Global Impression - is a single item, 4 point scale used by patients to asses their impression of severity of their illness and quality of their functioning in everyday life, where 1 is labeled as "Normal" and 4 is labeled as "Severe".
|
During 1st and 4th session within 2 weeks
|
Liebowitz Social Anxiety Scale
Délai: During 1st and 4th session within 2 weeks
|
Liebowitz Social Anxiety Scale (LSAS; Leibowitz, 1987) The scale is composed of 24 items, depicting various social situations. For each item, participants assess their fear (from 1 - "No fear" to 4 - "Severe") and avoidance (from 1 - "Never" to 4 - "Usually"). LSAS has 3 scores, summing the results for particular items - fear (0-72), avoidance (0-72) and total score (0-144). |
During 1st and 4th session within 2 weeks
|
Beck Depression Inventory
Délai: During 1st and 4th session within 2 weeks
|
During 1st and 4th session within 2 weeks
|
|
Subjective Units of Distress
Délai: During 2nd and 3th session within 2 weeks
|
Subjective Units of Distress (SUD) SUD is a subjective measure of perceived fear in certain situation. The scale range is from 0 ("Totally relaxed) to 100 ("Highest distress/fear/anxiety/discomfort that you have ever felt"). |
During 2nd and 3th session within 2 weeks
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Paweł Mierzejewski, prof, Tomorrow Sp. z o.o.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- POIR.01.01.01-00-0636/16-00
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Phobie sociale
-
University of PennsylvaniaComplétéComportement, social | Normes, SocialInde
-
Virginia Commonwealth UniversityNational Center for Advancing Translational Sciences (NCATS)ComplétéPsychologie, Social | Interaction sociale | Les relations interpersonnelles | Comportement, socialÉtats-Unis
-
Massachusetts Institute of TechnologyMassachusetts General HospitalPas encore de recrutement
-
Bright Vision HospitalSengkang Community Hospital; Outram Community HospitalPas encore de recrutement
-
Lifespan Healthcare Resource LimitedInconnue
-
Boston Medical CenterComplétéIsolement socialÉtats-Unis
-
University of California, Los AngelesComplété
-
Rigshospitalet, DenmarkRecrutement
-
Centre Hospitalier Universitaire de NicePas encore de recrutement
Essais cliniques sur VR Mind
-
Tomorrow Sp. z o.o.National Center for Research and Development, PolandComplété
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecrutementRéalité virtuelle | Douleur post-opératoire | Greffe de pontage coronarien | Chirurgie cardiaque | Anxiété post-opératoirePays-Bas
-
Johns Hopkins UniversityCenters for Medicare and Medicaid Services; Jewish Community Services; Johns...ComplétéDémence | Fardeau des soignantsÉtats-Unis
-
Johns Hopkins UniversityNational Institute on Aging (NIA); Thomas Jefferson UniversityComplétéDémence | Fardeau des soignantsÉtats-Unis
-
NHS Greater Glasgow and ClydeUniversity of GlasgowComplété
-
VA Office of Research and DevelopmentComplété
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Complété
-
Cairo UniversityComplétéDéclin cognitif | Trouble post-ménopausiqueEgypte
-
University of UlsterComplétéChangement cognitifRoyaume-Uni
-
University of SkövdeAlbert Einstein College of Medicine; Uppsala University; Göteborg University; University... et autres collaborateursPas encore de recrutementObésité | Stresser | Anxiété | Symptômes dépressifs | Dysbiose | Habitude alimentaireSuède